Skip to content
Screener

Amneal Pharmaceuticals, Inc. AMRX Specialty — Product marketing

Similar metrics at other companies

Church & Dwight logo
CHDSpecialty Products Division — Marketing And Advertising Expense
$600K-33.3%
Northrim BanCorp logo
NRIMSpecialty Finance — Marketing expense
$8K+167%
Associated Banc-Corp logo
ASBCorporate and Commercial Specialty — Marketing and Advertising Expense
$969K+3.7%
Teradyne, Inc. logo
TERProduct Test — Sales & Marketing
$13.11M+11.7%
NAG
NAGEConsumer Products segment — Marketing
$3.42M+39.5%
RE/MAX Holdings logo
RMAXMarketing Funds — Marketing And Advertising Expense
$16.79M-8.1%

Other financials

Income statement

See full
Revenue$796.2M+9.9%
Gross profit$334.5M+16.9%
Operating income$129.8M+16.5%
Net income$57.7M+157%
EPS (diluted)$0.18+157%

Balance sheet

See full
Cash & equivalents$127.6M+78.4%
Total debt$2.6B+18.0%
Total equity$33.0M+129%
Total assets$3.8B+10.3%

Cash flow

See full
Operating cash flow-$21.2M-125%
CapEx$30.7M+34.5%
Free cash flow-$51.9M-185%

Valuation

See full
Market cap$5.77B+129%
Enterprise value$8.21B+77.4%
P/E36.7×-711×
P/S1.9×+1.0×

Profitability

See full
Gross margin39.3%+1.7pp
Operating margin14.6%+1.4pp
Net margin5%+4.9pp
FCF margin4.1%-5.8pp

Returns & leverage

See full
Return on equity-52.8%-12.7pp
Debt / equity77.8×
Current ratio2.2×+0.8×

Where this comes from

Reported directly by Amneal Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:MarketingAndAdvertisingExpense.

The source filing: Amneal Pharmaceuticals, Inc.’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 5:19 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001723128-26-000031
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Employee compensation and benefits$12,938$10,791$24,873$21,663
Product marketing13,9919,88421,80817,895
Commercial operations and salesforce11,6028,78725,37519,578
Other (1)1,5648522,7302,156
Total$40,095$30,314$74,786$61,292

Item 1. Financial Statements (Unaudited)

FAQ

What is Amneal Pharmaceuticals, Inc.'s specialty — product marketing?
Amneal Pharmaceuticals, Inc. (AMRX) reported specialty — product marketing of $13.99M in Q2 2026.
How has Amneal Pharmaceuticals, Inc.'s specialty — product marketing changed year-over-year?
Amneal Pharmaceuticals, Inc.'s specialty — product marketing increased by 41.6% year-over-year, from $9.88M to $13.99M.
What is the long-term trend for Amneal Pharmaceuticals, Inc.'s specialty — product marketing?
Over 3 years (2022 to 2025), Amneal Pharmaceuticals, Inc.'s specialty — product marketing has grown at a 10.7% compound annual growth rate (CAGR), from $31.48M to $42.73M.
What does specialty — product marketing mean?
Reflects expenditures dedicated to advertising, brand promotion, and market awareness for specialty pharmaceutical products. It serves as a key indicator of the company's investment in driving demand and market share for its branded portfolio.

Ask your AI about Amneal Pharmaceuticals, Inc.'s specialty — product marketing.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude